Main Session
Sep
29
SS 37 - Radiation-Immune Crosstalk in Tumor and Normal Tissue Response
300 - A Novel Therapeutic Approach Using citVIM-specific CAR-T cells and Radiotherapy to Target NSCLC and Pancreatic Cancer Cells
Presenter(s)
Yorleny Vicioso Mora, MD, PhD, BS - Duke University, Durham, NC